awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33404763-9C7A66B1-F0ED-42D6-B9BC-B212E3ED2F28
Q33404763-9C7A66B1-F0ED-42D6-B9BC-B212E3ED2F28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404763-9C7A66B1-F0ED-42D6-B9BC-B212E3ED2F28
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study
P2860
Q33404763-9C7A66B1-F0ED-42D6-B9BC-B212E3ED2F28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404763-9C7A66B1-F0ED-42D6-B9BC-B212E3ED2F28
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a88f3619ddeeb11659240a00726d7033b3325f17
P2860
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.